NeuPath Health Inc. (TSXV:NPTH)
Canada · Delayed Price · Currency is CAD 0.5400
0.00 (0.00%)
Sep 10, 2026, 3:49 PM EST
NeuPath Health Ratios and Metrics
Market cap in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 31 | 28 | 12 | 10 | 9 | 23 | |
Market Cap Growth | 72.58% | 137.08% | 13.73% | 15.04% | -61.08% | -27.81% |
Enterprise Value | 41 | 37 | 20 | 19 | 22 | 34 |
Last Close Price | 0.54 | 0.50 | 0.21 | 0.18 | 0.18 | 0.50 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Forward PE | 5.86 | 9.78 | 9.78 | 9.78 | 9.78 | 11.11 |
PS Ratio | 0.35 | 0.32 | 0.16 | 0.16 | 0.14 | 0.38 |
PB Ratio | 1.31 | 1.34 | 0.55 | 0.48 | 0.42 | 0.90 |
P/TBV Ratio | 17.98 | - | 514.97 | 16.56 | 143.69 | 11.30 |
P/FCF Ratio | 12.77 | 8.55 | 7.14 | 3.89 | - | 15.42 |
P/OCF Ratio | 9.03 | 7.02 | 4.54 | 3.44 | 12.27 | 12.12 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 0.46 | 0.43 | 0.28 | 0.29 | 0.35 | 0.56 |
EV/EBITDA Ratio | 8.83 | 12.21 | 8.38 | 11.80 | - | - |
EV/EBIT Ratio | 17.13 | 18.25 | 14.43 | 43.29 | - | - |
EV/FCF Ratio | 16.97 | 11.31 | 12.25 | 7.15 | - | 22.50 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.56 | 0.63 | 0.53 | 0.56 | 0.65 | 0.64 |
Debt / EBITDA Ratio | 2.84 | 3.04 | 3.06 | 3.98 | 11.92 | 15.10 |
Debt / FCF Ratio | 5.46 | 4.00 | 6.84 | 4.53 | - | 10.88 |
Net Debt / Equity Ratio | 0.41 | 0.41 | 0.39 | 0.41 | 0.58 | 0.41 |
Net Debt / EBITDA Ratio | 2.88 | 2.85 | 3.47 | 5.52 | -73.55 | -40.23 |
Net Debt / FCF Ratio | 4.00 | 2.64 | 5.08 | 3.34 | -25.61 | 6.96 |
Asset Turnover | 1.97 | 2.02 | 1.75 | 1.52 | 1.30 | 1.25 |
Quick Ratio | 1.14 | 1.03 | 0.69 | 1.10 | 0.75 | 1.05 |
Current Ratio | 1.19 | 1.09 | 0.72 | 1.17 | 0.80 | 1.12 |
Return on Equity (ROE) | 7.24% | -1.95% | -2.24% | -0.88% | -18.01% | -12.08% |
Return on Assets (ROA) | 3.30% | 2.95% | 2.12% | 0.64% | -1.63% | -2.45% |
Return on Invested Capital (ROIC) | 7.46% | 6.85% | 4.65% | -4.72% | -3.56% | -5.82% |
Return on Capital Employed (ROCE) | 6.90% | 6.30% | 5.40% | 1.40% | -4.00% | -5.10% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 4.36% | -2.55% | -6.15% | -1.03% | -45.78% | -13.89% |
FCF Yield | 7.83% | 11.70% | 14.01% | 25.70% | -5.46% | 6.48% |
Buyback Yield / Dilution | -6.31% | -2.40% | -3.54% | -14.44% | -7.40% | -84.24% |